Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$7.84 - $23.29 $112,903 - $335,399
-14,401 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$5.57 - $11.5 $29,760 - $61,444
-5,343 Reduced 27.06%
14,401 $121,000
Q3 2019

Nov 14, 2019

BUY
$9.17 - $12.01 $26,272 - $34,408
2,865 Added 16.97%
19,744 $187,000
Q2 2019

Aug 14, 2019

BUY
$10.88 - $17.6 $183,643 - $297,070
16,879 New
16,879 $201,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.